Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
What is included with this book?
Abbreviations | p. xxiii |
Preface | p. xxvii |
Supplementary learning aids | p. xxviii |
Before we start - Intelligent use of the Internet | p. xxix |
The Basics | p. 1 |
DNA structure and gene expression | p. 3 |
Building blocks and chemical bonds in DNA, RNA and polypeptides | p. 4 |
DNA structure and replication | p. 8 |
Examples of the importance of hydrogen bonding in nucleic acids and proteins | p. 10 |
Major classes of proteins used in the DNA replication machinery | p. 12 |
RNA transcription and gene expression | p. 13 |
RNA processing | p. 19 |
Translation, post-translational processing and protein structure | p. 23 |
Chromosome structure and function | p. 33 |
Ploidy and the cell cycle | p. 34 |
Structure and function of chromosomes | p. 34 |
The mitotic spindle and its components | p. 37 |
Mitosis and meiosis are the two types of cell division | p. 40 |
Studying human chromosomes | p. 44 |
Chromosome banding | p. 48 |
Human chromosome nomenclature | p. 49 |
Chromosome abnormalities | p. 51 |
Nomenclature of chromosome abnormalities | p. 53 |
Cells and development | p. 59 |
The structure and diversity of cells | p. 60 |
Intracellular organization of animal cells | p. 62 |
The cytoskeleton: the key to cell movement and cell shape and a major framework for intracellular transport | p. 64 |
Cell interactions | p. 66 |
An overview of development | p. 71 |
The specialization of cells during development | p. 72 |
Animal models of development | p. 73 |
Twinning in human embryos | p. 74 |
Where our tissues come from - the developmental hierarchy in mammals | p. 75 |
The diversity of human cells | p. 76 |
Pattern formation in development | p. 79 |
Morphogenesis | p. 81 |
Polarizing the mammalian embryo - signals and gene products | p. 82 |
Early human development: fertilization to gastrulation | p. 86 |
Extra-embryonic membranes and the placenta | p. 89 |
Sex determination: genes and the environment in development | p. 93 |
Neural development | p. 94 |
Conservation of developmental pathways | p. 97 |
Genes in pedigrees and populations | p. 101 |
Monogenic versus multifactorial inheritance | p. 102 |
Mendelian pedigree patterns | p. 102 |
Characteristics of the Mendelian patterns of inheritance | p. 104 |
The complementation test to discover whether two recessive characters are determined by allelic genes | p. 106 |
Complications to the basic Mendelian pedigree patterns | p. 106 |
Genetics of multifactorial characters: the polygenic-threshold theory | p. 111 |
Two common misconceptions about regression to the mean | p. 114 |
Partitioning of variance | p. 115 |
Factors affecting gene frequencies | p. 117 |
Hardy-Weinberg equilibrium genotype frequencies for allele frequencies p(A1) and q (A2) | p. 117 |
The Hardy-Weinberg distribution can be used (with caution) to calculate carrier frequencies and simple risks for counseling | p. 118 |
Mutation-selection equilibrium | p. 118 |
Selection in favor of heterozygotes for CF | p. 119 |
Amplifying DNA: PCR and cell-based DNA cloning | p. 121 |
The importance of DNA cloning | p. 122 |
PCR: basic features and applications | p. 123 |
A glossary of PCR methods | p. 124 |
Principles of cell-based DNA cloning | p. 129 |
Restriction endonucleases and modification-restriction systems | p. 129 |
Nonsense suppressor mutations | p. 138 |
The importance of sequence tagged sites (STSs) | p. 138 |
Cloning systems for amplifying different sized fragments | p. 138 |
Cloning systems for producing single-stranded and mutagenized DNA | p. 144 |
Cloning systems designed to express genes | p. 147 |
Transferring genes into cultured animal cells | p. 152 |
Nucleic acid hybridization: principles and applications | p. 155 |
Preparation of nucleic acid probes | p. 156 |
Principles of autoradiography | p. 159 |
Principles of nucleic acid hybridization | p. 161 |
Fluorescence labeling and detection systems | p. 164 |
A glossary of nucleic acid hybridization | p. 166 |
Nucleic acid hybridization assays using cloned DNA probes to screen uncloned nucleic acid populations | p. 168 |
Standard and reverse nucleic acid hybridization assays | p. 169 |
Hybridization assays using cloned target DNA and microarrays | p. 174 |
Analyzing DNA and gene structure, variation and expression | p. 181 |
Sequencing and genotyping DNA | p. 182 |
Producing single-stranded DNA sequencing templates | p. 182 |
Identifying genes in cloned DNA and establishing their structure | p. 186 |
Common classes of DNA polymorphism which are amenable to simple genotyping methods | p. 187 |
Studying gene expression | p. 190 |
Database homology searching | p. 192 |
Obtaining antibodies | p. 200 |
The human genome and its relationship to other genomes | p. 205 |
Genome projects and model organisms | p. 207 |
The ground-breaking importance of genome projects | p. 208 |
A genomics glossary | p. 209 |
Background and organization of the Human Genome Project | p. 210 |
How the human genome was mapped and sequenced | p. 212 |
Human gene and DNA segment nomenclature | p. 212 |
Major milestones in mapping and sequencing the human genome | p. 213 |
Hybrid cell mapping | p. 215 |
Physical mapping by building clone contigs | p. 218 |
Co-operation, competition and controversy in the genome projects | p. 220 |
Genome projects for model organisms | p. 226 |
Model unicellular organisms | p. 227 |
Model multicellular animals for understanding development, disease and gene function | p. 230 |
Organization of the human genome | p. 239 |
General organization of the human genome | p. 240 |
Genome copy number variation in human cells | p. 242 |
The limited autonomy of the mitochondrial genome | p. 243 |
DNA methylation and CpG islands | p. 246 |
Organization, distribution and function of human RNA genes | p. 247 |
Anticodon specificity of eukaryotic cytoplasmic tRNAs | p. 249 |
Organization, distribution and function of human polypeptide-encoding genes | p. 253 |
Human genome and human gene statistics | p. 255 |
Tandemly repeated noncoding DNA | p. 265 |
Interspersed repetitive noncoding DNA | p. 268 |
Human gene expression | p. 275 |
An overview of gene expression in human cells | p. 276 |
Spatial and temporal restriction of gene expression in mammalian cells | p. 276 |
Control of gene expression by binding of trans-acting protein factors to cis-acting regulatory sequences in DNA and RNA | p. 277 |
Classes of cis-acting sequence elements involved in regulating transcription of polypeptide-encoding genes | p. 283 |
Alternative transcription and processing of individual genes | p. 291 |
Alternative splicing can alter the functional properties of a protein | p. 293 |
Differential gene expression: origins through asymmetry and perpetuation through epigenetic mechanisms such as DNA methylation | p. 294 |
Long range control of gene expression and imprinting | p. 298 |
Mechanisms resulting in monoallelic expression from biallelic genes in human cells | p. 302 |
The nonequivalence of the maternal and paternal genomes | p. 302 |
The unique organization and expression of Ig and TCR genes | p. 306 |
Instability of the human genome: mutation and DNA repair | p. 315 |
An overview of mutation, polymorphism, and DNA repair | p. 316 |
Simple mutations | p. 316 |
Classes of genetic polymorphisms and sequence variation | p. 317 |
Mechanisms that affect the population frequency of alleles | p. 319 |
Classes of single base substitution in polypeptide-encoding DNA | p. 321 |
Sex differences in mutation rate and the question of male-driven evolution | p. 326 |
Genetic mechanisms which result in sequence exchanges between repeats | p. 329 |
Pathogenic mutations | p. 331 |
The pathogenic potential of repeated sequences | p. 337 |
DNA repair | p. 344 |
Our place in the tree of life | p. 351 |
Evolution of gene structure and duplicated genes | p. 352 |
Intron groups | p. 353 |
Symmetrical exons and intron phases | p. 355 |
Gene duplication mechanisms and paralogy | p. 357 |
Evolution of chromosomes and genomes | p. 361 |
The universal tree of life and horizontal gene transfer | p. 362 |
Molecular phylogenetics and comparative genomics | p. 372 |
What makes us human? | p. 377 |
A glossary of common metazoan phylogenetic groups and terms | p. 383 |
Evolution of human populations | p. 385 |
Coalescence analyses | p. 389 |
Mapping and identifying disease genes and mutations | p. 395 |
Genetic mapping of Mendelian characters | p. 397 |
Recombinants and nonrecombinants | p. 398 |
Genetic markers | p. 402 |
The development of human genetic markers | p. 403 |
Informative and uninformative meioses | p. 404 |
Two-point mapping | p. 404 |
Calculation of lod scores for the families in Figure 13.6 | p. 406 |
Multipoint mapping is more efficient than two-point mapping | p. 407 |
Bayesian calculation of linkage threshold | p. 407 |
Fine-mapping using extended pedigrees and ancestral haplotypes | p. 408 |
Standard lod score analysis is not without problems | p. 411 |
Identifying human disease genes | p. 415 |
Principles and strategies in identifying disease genes | p. 416 |
Position-independent strategies for identifying disease genes | p. 416 |
Positional cloning | p. 418 |
Transcript mapping: laboratory methods that supplement database analysis for identifying expressed sequences within genomic clones | p. 421 |
Use of chromosomal abnormalities | p. 423 |
Mapping mouse genes | p. 423 |
Pointers to the presence of chromosome abnormalities | p. 426 |
Position effects - a pitfall in disease gene identification | p. 427 |
Confirming a candidate gene | p. 428 |
CGH for detecting submicroscopic chromosomal imbalances | p. 428 |
Eight examples illustrate various ways disease genes have been identified | p. 429 |
Mapping and identifying genes conferring susceptibility to complex diseases | p. 435 |
Deciding whether a non-Mendelian character is genetic: the role of family, twin and adoption studies | p. 436 |
Segregation analysis allows analysis of characters that are anywhere on the spectrum between purely Mendelian and purely polygenic | p. 437 |
Linkage analysis of complex characters | p. 439 |
Correcting the segregation ratio | p. 439 |
Association studies and linkage disequilibrium | p. 442 |
Measures of linkage disequilibrium | p. 443 |
The transmission disequilibrium test (TDT) to determine whether marker allele M[subscript 1] is associated with a disease | p. 446 |
Identifying the susceptibility alleles | p. 447 |
Sample sizes needed to find a disease susceptibility locus by a whole genome scan using either affected sib pairs (ASP) or the transmission disequilibrium test (TDT) | p. 447 |
Eight examples illustrate the varying success of genetic dissection of complex diseases | p. 448 |
Alzheimer disease, ApoE testing and discrimination | p. 452 |
Overview and summary | p. 457 |
Molecular pathology | p. 461 |
Introduction | p. 462 |
The convenient nomenclature of A and a alleles hides a vast diversity of DNA sequences | p. 462 |
A first classification of mutations is into loss of function vs. gain of function mutations | p. 462 |
The main classes of mutation | p. 462 |
Nomenclature for describing sequence changes | p. 463 |
A nomenclature for describing the effect of an allele | p. 463 |
Loss of function mutations | p. 465 |
Hemoglobinopathies | p. 465 |
Guidelines for assessing the significance of a DNA sequence change | p. 466 |
Gain of function mutations | p. 469 |
Molecular pathology: from gene to disease | p. 471 |
Molecular pathology of Prader-Willi and Angelman syndromes | p. 472 |
Molecular pathology: from disease to gene | p. 478 |
Molecular pathology of chromosomal disorders | p. 480 |
Cancer genetics | p. 487 |
Introduction | p. 488 |
The evolution of cancer | p. 488 |
Oncogenes | p. 489 |
Two ways of making a series of successive mutations more likely | p. 489 |
Tumor suppressor genes | p. 492 |
Stability of the genome | p. 497 |
Control of the cell cycle | p. 501 |
Integrating the data: pathways and capabilities | p. 502 |
What use is all this knowledge? | p. 504 |
Genetic testing in individuals and populations | p. 509 |
Introduction | p. 510 |
The choice of material to test: DNA, RNA or protein | p. 510 |
Scanning a gene for mutations | p. 511 |
Testing for a specified sequence change | p. 515 |
Multiplex amplifiable probe hybridization (MAPH) | p. 518 |
Gene tracking | p. 521 |
Two methods for high-throughput genotyping | p. 524 |
The logic of gene tracking | p. 527 |
Population screening | p. 529 |
Use of Bayes' theorem for combining probabilities | p. 529 |
DNA profiling can be used for identifying individuals and determining relationships | p. 532 |
The Prosecutor's Fallacy | p. 535 |
New horizons: into the 21st century | p. 537 |
Beyond the genome project: functional genomics, proteomics and bioinformatics | p. 539 |
An overview of functional genomics | p. 540 |
The function of glucokinase | p. 541 |
Functional annotation by sequence comparison | p. 541 |
Global mRNA profiling (transcriptomics) | p. 545 |
Sequence sampling techniques for the global analysis of gene expression | p. 547 |
Proteomics | p. 553 |
Protein chips | p. 554 |
Mass spectrometry in proteomics | p. 557 |
Determination of protein structures | p. 563 |
Structural classification of proteins | p. 567 |
Summary | p. 572 |
Genetic manipulation of cells and animals | p. 575 |
An overview of gene transfer technology | p. 576 |
Principles of gene transfer | p. 576 |
Methods of gene transfer to animal cells in culture | p. 578 |
Selectable markers for animal cells | p. 579 |
Isolation and manipulation of mammalian embryonic stem cells | p. 582 |
Using gene transfer to study gene expression and function | p. 594 |
Reporter genes for animal cells | p. 595 |
Sophisticated vectors used for insertional mutagenesis | p. 599 |
Creating disease models using gene transfer and gene targeting technology | p. 599 |
The potential of animals for modeling human disease | p. 603 |
New approaches to treating disease | p. 609 |
Treatment of genetic disease is not the same as genetic treatment of disease | p. 610 |
Treatment of genetic disease | p. 610 |
Using genetic knowledge to improve existing treatments and develop new versions of conventional treatments | p. 610 |
The ethics of human cloning | p. 614 |
Principles of gene therapy | p. 616 |
Methods for inserting and expressing a gene in a target cell or tissue | p. 616 |
Germ line versus somatic gene therapy | p. 617 |
1995 NIH Panel report on gene therapy (Orkin-Motulsky report) | p. 619 |
Designer babies | p. 619 |
Methods for repairing or inactivating a pathogenic gene in a cell or tissue | p. 624 |
Some examples of attempts at human gene therapy | p. 625 |
Glossary | p. 631 |
Disease index | p. 645 |
Index | p. 647 |
Table of Contents provided by Ingram. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.